SupplySide West In Brief
This article was originally published in The Tan Sheet
Executive Summary
Condition-targeted probiotics: Danisco stresses the condition-specific science behind its probiotics with the launch of HOWARU Restore. According to the firm, a placebo-controlled study of antibiotic users found the bifidobacteria levels in individuals taking Restore returned to baseline "immediately following antibiotic therapy." The number and balance of healthy intestinal microflora were also better maintained in the treatment group. "Many probiotic suppliers employ a one-strain-does-it-all approach to probiotic efficacy," Global Probiotics Business Director Scott Bush said. "Danisco's unique screening strategy utilizing in vitro and in vivo models allows selection of the best strain or blend for each condition," he continued. The antibiotic study is the "first in a line of condition-specific studies by Danisco," according to Bush. The newest probiotic blend under the HOWARU umbrella is recommended for use in supplements and nutritionals and can be stored for up to two years in dry, capsule form, Danisco says...
You may also be interested in...
FDA Intervention In Kava Labeling Suit Sought By Jarrow Formulas
FDA should release an official statement or publish a proposed rule requiring warnings on kava supplements "if available sound science supports such rulemaking," Jarrow Formulas says in an Oct. 4 citizen petition
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands